Keyphrases
1-year Survival
20%
Adoptive Immunotherapy
100%
Clinical Efficacy
10%
Combination Therapy
10%
Complete Response
10%
Cytotoxic Lymphocytes
100%
Cytotoxic T Lymphocytes
40%
Dendritic Cells
100%
Disease Control
10%
Effective Treatment
10%
Electroporation
10%
Familial Pancreatic Cancer
20%
Gemcitabine
100%
Granulocyte Colony-stimulating Factor (G-CSF)
10%
Human Pancreatic Cancer Cell Line
10%
Interleukin-2
10%
Interleukin-4 (IL-4)
10%
Liver Metastasis
20%
Median Survival Time
20%
Mucin 1 (MUC1)
100%
Pancreatic Cancer
10%
Partial Response
10%
Regulatory T Cells
10%
Resectable Pancreatic Cancer
100%
Severe Toxicity
10%
Stable Disease
10%
Tumor Immunity
10%
Tumor Necrosis Factor-α
10%
Medicine and Dentistry
Adoptive Immunotherapy
100%
Calcium Ion
10%
Combination Therapy
10%
Cytotoxic Lymphocyte
100%
Cytotoxic T-Cell
40%
Dendritic Cell
100%
Disease
20%
Electroporation
10%
Gemcitabine
100%
Granulocyte Macrophage Colony Stimulating Factor
10%
Interleukin 2
10%
Interleukin 4
10%
Liver Metastasis
20%
Median Survival Time
20%
Mucin 1
100%
Pancreas Cancer
100%
Pancreatic Cancer Cell Line
10%
Regulatory T Cell
10%
Survival Rate
20%
Tumor Immunity
10%
Tumor Necrosis Factor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Calcium Ion
10%
Combination Therapy
10%
Disease
20%
Gemcitabine
100%
Granulocyte Macrophage Colony Stimulating Factor
10%
Immunotherapy
100%
Interleukin 2
10%
Interleukin 4
10%
Liver Metastasis
20%
Median Survival Time
20%
Mucin 1
100%
Neoplasm
10%
Pancreas Cancer
100%
Survival Rate
20%
Tumor Necrosis Factor
10%